Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin glargine.

Literature DB >> 10981882

Insulin glargine.

G B Bolli¹, D R Owens.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2000 PMID： 10981882 DOI： 10.1016/S0140-6736(00)02546-0

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. Type 1 diabetes: recent developments.

Authors: Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal: BMJ Date: 2004-03-27

2. Hypoglycemia and insulin treatment.

Authors: F Febo; C Molinari; P M Piatti
Journal: J Endocrinol Invest Date: 2011-10 Impact factor: 4.256

Review 3. Insulin therapy in children and adolescents with type 1 diabetes.

Authors: Faisal S Malik; Craig E Taplin
Journal: Paediatr Drugs Date: 2014-04 Impact factor: 3.022

4. Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters.

Authors: Jerzy Sitkowski; Wojciech Bocian; Elżbieta Bednarek; Mateusz Urbańczyk; Wiktor Koźmiński; Piotr Borowicz; Grażyna Płucienniczak; Natalia Łukasiewicz; Iwona Sokołowska; Lech Kozerski
Journal: J Biomol NMR Date: 2018-06-12 Impact factor: 2.835

5. Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Authors: Sandra Reichstetter; Gerardo M Castillo; ManShun Lai; Akiko Nishimoto-Ashfield; Aryamitra Banerjee; Alexei Bogdanov; Alexander V Lyubimov; Elijah M Bolotin
Journal: Pharm Res Date: 2011-12-28 Impact factor: 4.200

Review 6. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.

Authors: K McKeage; K L Goa
Journal: Drugs Date: 2001 Impact factor: 9.546

Insulin glargine.

Review 1. Type 1 diabetes: recent developments.

2. Hypoglycemia and insulin treatment.

Review 3. Insulin therapy in children and adolescents with type 1 diabetes.

4. Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters.

5. Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Review 6. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.

Review 7. Insulin analogues: new therapies for type 2 diabetes mellitus.

8. The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin.

Review 9. Defining the role of insulin detemir in Basal insulin therapy.

Review 10. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.